Average Co-Inventor Count = 9.30
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (26 from 410 patents)
2. Janssen Pharmaceutica Nv (3 from 2,076 patents)
3. Centocor Ortho Biotech Inc. (2 from 31 patents)
4. Jansson Biotech, Inc. (1 from 1 patent)
32 patents:
1. 11884722 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
2. 11787875 - Materials and methods for improved single chain variable fragments
3. 11732050 - Neutralizing human anti-CD27 antibodies
4. 11685777 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
5. 11421037 - Nucleic acids encoding anti-CD154 antibodies
6. 11414484 - Anti-CCL17 antibodies
7. 11208450 - GM-CSF variants and methods of use
8. 10844122 - Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
9. 10829549 - Anti-CCL17 antibodies
10. 10689453 - Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies
11. 10669343 - Anti-CD154 antibodies and methods of using them
12. 10562968 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
13. 10562948 - GM-CSF variants and methods of use
14. 10544229 - Agonistic antibodies specifically binding CD40 and methods of use
15. 10301392 - Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies